OEM News, Regulatory

Canadian Regulators Authorize the Venus Bliss MAX

The body shaping solution was first made available in the United States in early 2022.

By: Michael Barbella

Managing Editor

Venus Concept Inc. has received a medical device license from Health Canada for the Venus Bliss MAX system, a product that was first available in the United States in early 2022 and subsequently offered in approved jurisdictions worldwide.
 
The Venus Bliss MAX is a three-in-one body shaping solution featuring three of the company’s technologies in one platform: the diode laser for fat reduction treatments; the proprietary (MP)2 applicator that combines multi-polar radio frequency with pulsed electro magnetic fields and advanced VariPulse technology for cellulite reduction and skin treatments; and the FlexMax EMS applicators for muscle toning and conditioning.
 
“Venus continues to expand the availability of our flagship body platform, the Venus Bliss MAX, with our entry into Canada, providing our customers a comprehensive solution to deliver multiple advanced non-invasive body treatments in one system,” Venus Concept President/CEO Dr. Hemanth Varghese said. “Clinicians and aesthetic practices of all experiences and size in the Canadian market will benefit from this combination of proprietary technologies, further elevating the results they can deliver to the evolving aesthetic marketplace.”
 
Venus Concept is a global medical aesthetic technology firm with a product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reach in more 60 countries and 12 direct markets. Venus Concept’s products consist of aesthetic device platforms, including Venus Versa, Venus Versa Pro, Venus Legacy, Venus Velocity, Venus Viva, Venus Glow, Venus Bliss, Venus Bliss MAX, Venus Epileve, Venus Viva MD and AI.ME. Venus Concept’s hair restoration systems include NeoGraft and the ARTAS iX Robotic Hair Restoration system. Venus Concept has been backed by healthcare industry growth equity investors including EW Healthcare Partners (formerly Essex Woodlands), HealthQuest Capital, Longitude Capital Management, Aperture Venture Partners, and Masters Special Situations.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters